Fetus as a patient in pregnant women with COVID-19

Authors

  • Alexandra Rivero Fraute 1Médico Especialista en Obstetricia y Ginecología y Perinatología. UCV. Coordinadora del programa de especialización en Medicina Materno Fetal. Universidad Central de Venezuela
  • Carlos Cabrera Especialista en Docencia en Educación Superior. Director del programa de especialización en Medicina Materno Fetal, Universidad Central de Venezuela.
  • Pedro Faneite
  • Paulino Vigil-De Gracia
  • César Cuadra

Keywords:

Fetus, placenta, COVID-19.

Abstract

Fetus and placenta are an immunologically privileged unit, whose physiological changes during pregnancy intervenes in the behavior
against SARS-CoV- 2, describing a theoretical potential teratogenic damage due to receptors ACE-2 expression, necessary for SARS-CoV-2 intracellular transport in the epiblast, vital in organogenesis, as well as the current pharmacological therapy teratogenic effects, abortions, and fetal demise.

Downloads

How to Cite

Rivero Fraute, A., Cabrera, C., Faneite, P., Vigil-De Gracia, P., & Cuadra, C. (2021). Fetus as a patient in pregnant women with COVID-19. Gaceta Médica De Caracas, 129(2), 415–420. Retrieved from https://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/22503

Issue

Vol. 129 No. 2 (2021)

Section

ARTÍCULOS DE REVISIÓN

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.